Home
>
National Drug Code (NDC)
>
mirtazapine
mirtazapine - 43063-255-30 - (mirtazapine)
Drug Information of mirtazapine
| Product NDC: | 43063-255 |
| Proprietary Name: | mirtazapine |
| Non Proprietary Name: | mirtazapine |
| Active Ingredient(s): | 30 mg/1 & nbsp; mirtazapine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of mirtazapine
| Product NDC: | 43063-255 |
| Labeler Name: | PD-Rx Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076219 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20030619 |
Package Information of mirtazapine
| Package NDC: | 43063-255-30 |
| Package Description: | 30 TABLET, FILM COATED in 1 BOTTLE (43063-255-30) |
NDC Information of mirtazapine
| NDC Code | 43063-255-30 |
| Proprietary Name | mirtazapine |
| Package Description | 30 TABLET, FILM COATED in 1 BOTTLE (43063-255-30) |
| Product NDC | 43063-255 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | mirtazapine |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20030619 |
| Marketing Category Name | ANDA |
| Labeler Name | PD-Rx Pharmaceuticals, Inc. |
| Substance Name | MIRTAZAPINE |
| Strength Number | 30 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |
